Abstract
Through a general retrospective analysis of the IL-1RAmspa11,100 (rs315952) cytokine gene polymorphism’s genotypes and alleles, the T/T genotype, along with the individual T allele, shows significant associations with the risk of Systemic Lupus Erythematosus (SLE). Meanwhile, the C/C and C/T genotypes, as well as the individual C allele, exhibited no significant associations. These results imply that having a homozygous genotype for the T allele increases the likelihood of SLE occurrence, while having a single C allele may induce a protective effect against the disease. To obtain these results, the researchers employed the analysis of six selected case-control and cross-sectional studies on healthy individuals SLE patients diagnosed through PCR tests. Forest plot construction was done to assess potential overlapping confidence intervals among the qualified studies. To identify the degree of heterogeneity among the papers, the odds ratio and the total confidence intervals, with the confidence interval set at 95%, were acquired through fixed and random effects models. Genotype and allele analyses with I2 statistics higher than 40% led to the funnel plot construction for outlier detection. Currently, the underlying processes that led to these genes’ and alleles’ varying outcomes to SLE risk remain elusive. Meanwhile, the subjects’ IL-1RA haplotypes may undermine these findings, along with the need for environmental consideration and the potential alteration of the gene and its corresponding alleles due to epigenetics. However, these findings still remain a possible starting point or reference for future studies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at: PubMed, Springer, Cochrane Library, and as well as search engines like EBSCOHost Platform and Google Scholar
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Data Availability
The raw data for the data mining process, and the files for the statistical analyses that support the current study were not publicly made available. However, the authors can be reached out through their emails if in need of a copy concerning the Microsoft Excel file for the screening process, and the RevMan 5.4.1. file enlisting the partial results, provided that the intention for requesting the files were valid.
